Cargando…
Mitochondrial diseases: expanding the diagnosis in the era of genetic testing
Mitochondrial diseases are clinically and genetically heterogeneous. These diseases were initially described a little over three decades ago. Limited diagnostic tools created disease descriptions based on clinical, biochemical analytes, neuroimaging, and muscle biopsy findings. This diagnostic mecha...
Autor principal: | Saneto, Russell P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791531/ https://www.ncbi.nlm.nih.gov/pubmed/33426505 http://dx.doi.org/10.20517/jtgg.2020.40 |
Ejemplares similares
-
The genetics of Leigh syndrome and its implications for clinical practice and risk management
por: Ruhoy, Ilene S, et al.
Publicado: (2014) -
Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience
por: Maguolo, A., et al.
Publicado: (2020) -
Alpers–Huttenlocher syndrome: the role of a multidisciplinary health care team
por: Saneto, Russell P
Publicado: (2016) -
Mitochondria-Associated Membrane Scaffolding with Endoplasmic Reticulum: A Dynamic Pathway of Developmental Disease
por: Saneto, Russell P., et al.
Publicado: (2022) -
The Switch in the Diagnosis of Mitochondrial Diseases from the Classical ‘Function First’ To the NGS-based ‘Genetics First’ Diagnostic Era
por: Sperl, Wolfgang, et al.
Publicado: (2020)